Abstract
Libraries displaying random peptides on the surface of adeno-associated virus (AAV) are powerful tools for the generation of target-specific gene therapy vectors. However, for unknown reasons the success rate of AAV library screenings is variable and the influence of the production procedure has not been thoroughly evaluated. During library screenings, the capsid variants with the most favorable tropism are enriched over several selection rounds on a target of choice and identified by subsequent sequencing of the encapsidated viral genomes encoding the library capsids with targeting peptide insertions. Thus, a high capsid-genome correlation is crucial to obtain the correct information about the selected capsid variants. Producing AAV libraries by a two-step protocol with pseudotyped library transfer shuttles has been proposed as one way to ensure such a correlation. Here we show that AAV2 libraries produced by such a protocol via transfer shuttles display an unexpected additional bias in the amino-acid composition which confers increased heparin affinity and thus similarity to wildtype AAV2 tropism. This bias may fundamentally impair the intended use of AAV libraries, discouraging the use of transfer shuttles for the production of AAV libraries in the future.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Identification of adeno-associated virus variants for gene transfer into human neural cell types by parallel capsid screening
Scientific Reports Open Access 19 May 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout






References
Müller OJ, Kaul F, Weitzman MD, Pasqualini R, Arap W, Kleinschmidt JA et al. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol 2003; 21: 1040–1046.
Perabo L, Buning H, Kofler DM, Ried MU, Girod A, Wendtner CM et al. In vitro selection of viral vectors with modified tropism: The adeno-associated virus display. Mol Ther 2003; 8: 151–157.
Waterkamp DA, Muller OJ, Ying Y, Trepel M, Kleinschmidt JA . Isolation of targeted AAV2 vectors from novel virus display libraries. J Gene Med 2006; 8: 1307–1319.
Grimm D, Lee JS, Wang L, Desai T, Akache B, Storm TA et al. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and re-targeting of adeno-associated viruses. J Virol 2008; 82: 5887–5911.
Varadi K, Michelfelder S, Korff T, Hecker M, Trepel M, Katus HA et al. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors. Gene Ther 2012; 19: 800–809.
Naumer M, Ying Y, Michelfelder S, Reuter A, Trepel M, Muller OJ et al. Development and validation of novel AAV2 random libraries displaying peptides of diverse lengths and at diverse capsid positions. Hum Gene Ther 2012; 23: 492–507.
Boucas J, Lux K, Huber A, Schievenbusch S, von Freyend MJ, Perabo L et al. Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations. J Gene Med 2009; 11: 1103–1113.
Marsic D, Zolotukhin S . Altering tropism of rAAV by directed evolution. Methods Mol Biol 2016; 1382: 151–173.
Michelfelder S, Lee MK, Delima-Hahn E, Wilmes T, Kaul F, Muller O et al. Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy. Exp Hematol 2007; 35: 1766–1776.
Sellner L, Stiefelhagen M, Kleinschmidt JA, Laufs S, Wenz F, Fruehauf S et al. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells. Exp Hematol 2008; 36 (8): 957–964.
Stiefelhagen M, Sellner L, Kleinschmidt JA, Jauch A, Laufs S, Wenz F et al. Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line. Genet Vaccines Ther 2008; 6: 12.
Koerber JT, Klimczak R, Jang JH, Dalkara D, Flannery JG, Schaffer DV . Molecular evolution of adeno-associated virus for enhanced glial gene delivery. Mol Ther 2009; 17: 2088–2095.
Marsch S, Huber A, Hallek M, Buning H, Perabo L . A novel directed evolution method to enhance cell-type specificity of adeno-associated virus vectors. Combin Chem High Throughp Screen 2010; 13: 807–812.
Michelfelder S, Kohlschutter J, Skorupa A, Pfennings S, Muller O, Kleinschmidt JA et al. Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display Peptide libraries. PLoS ONE 2009; 4: e5122.
Ying Y, Muller OJ, Goehringer C, Leuchs B, Trepel M, Katus HA et al. Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library. Gene Ther 2010; 17: 980–990.
Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH et al. in vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med 2013; 5: 189ra176.
Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol 2016; 34: 204–209.
Körbelin J, Sieber T, Michelfelder S, Lunding L, Spies E, Hunger A et al. Pulmonary targeting of adeno-associated viral vectors by next-generation sequencing-guided screening of random capsid displayed peptide libraries. Mol Ther 2016; 24: 1050–1061.
Körbelin J, Dogbevia G, Michelfelder S, Ridder DA, Hunger A, Wenzel J et al. A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med 2016; 8: 609–625.
Nonnenmacher M, van Bakel H, Hajjar RJ, Weber T . High capsid-genome correlation facilitates creation of AAV libraries for directed evolution. Mol Ther 2015; 23: 675–682.
Perabo L, Goldnau D, White K, Endell J, Boucas J, Humme S et al. Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism. J Virol 2006; 80: 7265–7269.
Sieber T, Hare E, Hofmann H, Trepel M . Biomathematical description of synthetic peptide libraries. PLoS ONE 2015; 10: e0129200.
Krumpe LR, Schumacher KM, McMahon JB, Makowski L, Mori T . Trinucleotide cassettes increase diversity of T7 phage-displayed peptide library. BMC Biotechnol 2007; 7: 65.
Kern A, Schmidt K, Leder C, Muller OJ, Wobus CE, Bettinger K et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol 2003; 77: 11072–11081.
Virnekas B, Ge L, Pluckthun A, Schneider KC, Wellnhofer G, Moroney SE . Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Res 1994; 22: 5600–5607.
Kayushin AL, Korosteleva MD, Miroshnikov AI, Kosch W, Zubov D, Piel N . A convenient approach to the synthesis of trinucleotide phosphoramidites—synthons for the generation of oligonucleotide/peptide libraries. Nucleic Acids Res 1996; 24: 3748–3755.
Palfrey D, Picardo M, Hine AV . A new randomization assay reveals unexpected elements of sequence bias in model 'randomized' gene libraries: implications for biopanning. Gene 2000; 251: 91–99.
Aird D, Ross MG, Chen WS, Danielsson M, Fennell T, Russ C et al. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol 2011; 12: R18.
Ward P, Clement N, Linden RM . cis effects in adeno-associated virus type 2 replication. J Virol 2007; 81: 9976–9989.
Kayushin A, Korosteleva M, Miroshnikov A . Large-scale solid-phase preparation of 3'-unprotected trinucleotide phosphotriesters—precursors for synthesis of trinucleotide phosphoramidites. Nucleosides Nucleotides Nucleic Acids 2000; 19: 1967–1976.
Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224–2232.
Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999; 6: 973–985.
Acknowledgements
We are grateful to Anna Oberle, Simon Schliffke and Nuray Akyüz, University Medical Center Hamburg-Eppendorf, Germany, for their technical support and expertise regarding the next-generation sequencing. We thank Hans O. Pinnschmidt, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf for statistical consulting and we thank Jude Samulski, University of North Carolina, Chapel Hill, NC for kindly providing the plasmid pXX6 and This work was supported by the Deutsche Krebshilfe (grant 110902 to MT) and the Margarete Clemens Foundation (endowed professorship to MT).
Author contributions
Designed the experiments: JK, MT. Performed the experiments: JK, AH. Analyzed the data: JK, AH, MA. Discussed the data: JK, MA, MB, MT. Contributed material/technical equipment: TS, MB. Wrote the manuscript: JK, MT.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Gene Therapy website
Supplementary information
Rights and permissions
About this article
Cite this article
Körbelin, J., Hunger, A., Alawi, M. et al. Optimization of design and production strategies for novel adeno-associated viral display peptide libraries. Gene Ther 24, 470–481 (2017). https://doi.org/10.1038/gt.2017.51
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2017.51
This article is cited by
-
Identification of adeno-associated virus variants for gene transfer into human neural cell types by parallel capsid screening
Scientific Reports (2022)
-
The current landscape of nucleic acid therapeutics
Nature Nanotechnology (2021)